Comparison of a New Triazole, Posaconazole, with Itraconazole and Amphotericin B for Treatment of Histoplasmosis following Pulmonary Challenge in Immunocompromised Mice

類似資料

• Comparison of a New Triazole Antifungal Agent, Schering 56592, with Itraconazole and Amphotericin B for Treatment of Histoplasmosis in Immunocompetent Mice
  著者:: Connolly, Patricia, 等
  出版事項: (1999)
• Comparison of Nikkomycin Z with Amphotericin B and Itraconazole for Treatment of Histoplasmosis in a Murine Model
  著者:: Goldberg, Janet, 等
  出版事項: (2000)
• Comparison of the Echinocandin Caspofungin with Amphotericin B for Treatment of Histoplasmosis following Pulmonary Challenge in a Murine Model
  著者:: Kohler, Steve, 等
  出版事項: (2000)
• Clearance of Fungal Burden during Treatment of Disseminated Histoplasmosis with Liposomal Amphotericin B versus Itraconazole
  著者:: Wheat, L. Joseph, 等
  出版事項: (2001)
• Antigen Clearance during Treatment of Disseminated Histoplasmosis with Itraconazole versus Fluconazole in Patients with AIDS
  著者:: Wheat, L. Joseph, 等
  出版事項: (2002)